Doxazosin
- Product NDC
- 71335-3081
- 11-digit product format
- 713353081
- Labeler code
- 71335
- Product ID
- 71335-3081_0070fa6a-c4ec-4f86-aedf-73e956c00d58
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA075536
- Marketing category
- ANDA
- Marketing start
- 2014-08-06
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197626 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-3081-1 | 71335308101 | 30 TABLET in 1 BOTTLE (71335-3081-1) | 30 tablet | 2026-02-13 | No | No | Historical |
| 71335-3081-2 | 71335308102 | 60 TABLET in 1 BOTTLE (71335-3081-2) | 60 tablet | 2026-02-13 | No | No | Historical |
| 71335-3081-3 | 71335308103 | 90 TABLET in 1 BOTTLE (71335-3081-3) | 90 tablet | 2026-02-13 | No | No | Historical |
| 71335-3081-4 | 71335308104 | 28 TABLET in 1 BOTTLE (71335-3081-4) | 28 tablet | 2026-02-13 | No | No | Historical |
| 71335-3081-5 | 71335308105 | 18 TABLET in 1 BOTTLE (71335-3081-5) | 18 tablet | 2026-02-13 | No | No | Historical |